Cost-effectiveness analysis of platinum-based chemotherapy treatment options for germline BRCA-mutated locally advanced/borderline resectable pancreatic cancer.

Myles Ingram,Yoanna S Pumpalova,Jiheum Park,Francesca Lim,Gulam Abbas Manji,Chung Yin Kong,Chin Hur

Cost-effectiveness analysis of platinum-based chemotherapy treatment options for germline BRCA-mutated locally advanced/borderline resectable pancreatic cancer.

2021

Myles Ingram
Yoanna S Pumpalova
Jiheum Park
Francesca Lim
Gulam Abbas Manji
Chung Yin Kong
Chin Hur

e16246Background: Patients with germline BRCA1/2 mutations (gBRCAm) have an increased risk for pancreatic ductal adenocarcinoma (PDAC). The NCCN 2020 guidelines recommend platinum-based chemotherap...

Keywords:

treatment options
borderline resectable
Medicine
locally advanced
Pancreatic cancer
Internal medicine
Chemotherapy
Germline
Oncology
Cost-effectiveness analysis
pancreatic ductal adenocarcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations